[The radiation oncologist, one of the actors in the patient's path after cancer. Follow up after prostate cancer]

Cancer Radiother. 2019 Oct;23(6-7):565-571. doi: 10.1016/j.canrad.2019.07.148. Epub 2019 Aug 22.
[Article in French]

Abstract

Prostate cancer is the most common cancer of men over 50 years old. Localized prostatic cancer treatment may be responsible of a decline of patient's quality of life. The main actors of treatment are now focused on minimizing functional consequences of treatments. The radiation oncologist has a central role in patient monitoring. The follow-up is codified by official recommendations of learned societies to enhance the post-cancer period. The main objective of this article is to review the recommendations for clinical and biological follow-up. An inventory of the functional consequences of the various treatments will be detailed, and particularly those caused by androgen deprivation therapy, with a review of precautions before implementation, adverse effects and their management, as well as monitoring recommendations. The analysis of quality of life after curative treatment and suggestions to improve monitoring will also be discussed.

Keywords: Cancer de la prostate; Follow-up; Patient–related outcomes; Prostate cancer; Quality of life; Qualité de vie; Surveillance.

Publication types

  • Review

MeSH terms

  • Aftercare / standards*
  • Aged
  • Androgen Antagonists / therapeutic use
  • Brachytherapy
  • Follow-Up Studies
  • Humans
  • Male
  • Middle Aged
  • Patient Reported Outcome Measures
  • Physician's Role*
  • Practice Guidelines as Topic
  • Prostate-Specific Antigen / blood
  • Prostatectomy
  • Prostatic Neoplasms / blood
  • Prostatic Neoplasms / therapy*
  • Quality of Life
  • Radiation Oncologists*
  • Sexual Dysfunction, Physiological / therapy
  • Treatment Outcome

Substances

  • Androgen Antagonists
  • Prostate-Specific Antigen